GKOS
$164.19+3.56%
as of close, Sep 30, 2026
☾ AH $164.19 +3.56%
GKOS — Glaukos Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
40.060.080.0100.0120.0140.0160.0180.0010.0M$164.19—20162019202120242026
2026-09-30
Price$164.19
MA20$150.05
MA50$120.51
Vol4.5M
Key stats
Price data
- Price
- $164.19
- Change YTD
- +45.42%
- Next earnings
- Nov 4, 2026
- Market cap
- 9.7B
- Enterprise value
- 9.7B
- Shares outstanding
- 59M
- 52W low
- $73.16
- 52W high
- $191.62
- From 52W high
- -14.31%
- From 52W low
- +124.43%
- 52W range
- 77%
- Beta
- 0.75
Volume
- Rel volume
- 1.11×
- 30D volume
- 750.9K
- 30D $ vol
- 127.8M
Fundamentals
- Sales (ttm)
- 612.8M
- Sales/share
- $10.39
- EPS (ttm)
- -$3.25
- FCF (ttm)
- -12.2M
- FCF/share
- -$0.21
- Book value/share
- $11.57
- Net margin
- -30.68%
- ROE
- -27.55%
- ROA
- -20.43%
- Current ratio
- 5.04
Growth (CAGR, ttm) · 10Y
- Sales
- +41.58%+27.33%+16.62%+21.03%
- Shares
- +2.85%+6.63%+4.84%+5.97%
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +37.66%+19.42%+11.23%+14.20%
- Book value/share
- -13.28%+4.82%-1.61%+13.78%
- Price
- +101.43%+29.66%+27.80%+15.89%
- Total return
- +101.43%+29.66%+27.80%+15.89%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -50.6×
- Fwd P/E
- 311.9×
- P/S (ttm)
- 15.8×
- P/B (mrq)
- 14.2×
- EV/Sales (ttm)
- 15.8×
- FCF yield (ttm)
- -0.13%
- Buyback yield (realized, 1y)
- -2.85%
- Shareholder yield (realized, 1y)
- -2.85%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 87th
- P/B
- 94th
- P/FCF
- 57th
Bar = where today’s multiple sits in GKOS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-30
1D
+3.56%
5D
+6.97%
1M
-8.72%
3M
+17.48%
YTD
+45.42%
1Y
+101.34%
5Y
+240.86%
Financial statements
Open full GKOS financials →Loading financial statements…
Related Health Care
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -7.31% | -2.15% |
| NVO | Novo Nordisk A/S | -16.88% | -1.04% |
| SNY | Sanofi ADS | -8.01% | +1.20% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -5.21% | -2.39% |
| NTRA | Natera Inc. | +26.68% | -0.29% |
| ARGX | argenx SE American Depositary Shares | -6.28% | -1.21% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | +0.89% | -1.73% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +8.67% | -0.53% |
